Execs not worried by reform talk . . .

Top Drug Makers Keep Price Hikes Shy Of 10 Percent

January 11, 2018
New analysis from a top investment firm reveals that a number of the world's top drug companies increased drug prices by just below 10 percent in late December and early January. While keeping hikes below 10 percent allows the companies to follow along with the so-called social contract with consumers first started by Allergan, two consumer groups are still calling foul. Despite some murmuring by consumer advocates about these price increases, industry leaders appear calm over the threat of top-down...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.